NDC Package 45802-238-65 Alogliptin And Pioglitazone

View Billable Units, 11-Digit Format, RxNorm

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
45802-238-65
Package Description:
30 TABLET, FILM COATED in 1 BOTTLE
Product Code:
Proprietary Name:
Alogliptin And Pioglitazone
Usage Information:
History of a serious hypersensitivity reaction to alogliptin or pioglitazone, components of alogliptin and pioglitazone tablets, such as anaphylaxis, angioedema or severe cutaneous adverse reactions.Do not initiate in patients with NYHA Class III or IV heart failure [see Boxed Warning].
11-Digit NDC Billing Format:
45802023865
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
30 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 1368410 - alogliptin 12.5 MG / pioglitazone 30 MG Oral Tablet
  • RxCUI: 1368410 - alogliptin 12.5 MG (as alogliptin benzoate 17 MG) / pioglitazone 30 MG (as pioglitazone hydrochloride 33.06 MG) Oral Tablet
  • RxCUI: 1368424 - alogliptin 25 MG / pioglitazone 15 MG Oral Tablet
  • RxCUI: 1368424 - alogliptin 25 MG (as alogliptin benzoate 34 MG) / pioglitazone 15 MG (as pioglitazone hydrochloride 16.53 MG) Oral Tablet
  • RxCUI: 1368431 - alogliptin 25 MG / pioglitazone 30 MG Oral Tablet
Labeler Name:
Padagis Israel Pharmaceuticals Ltd
Sample Package:
No
FDA Application Number:
NDA022426
Marketing Category:
NDA AUTHORIZED GENERIC - A product marketed as a "generic" drug under an approved New Drug Application (NDA), rather than an Abbreviated New Drug Application (ANDA),.
Start Marketing Date:
04-08-2016
End Marketing Date:
09-13-2024
Listing Expiration Date:
09-13-2024
Exclude Flag:
D
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 45802-238-65?

The NDC Packaged Code 45802-238-65 is assigned to a package of 30 tablet, film coated in 1 bottle of Alogliptin And Pioglitazone, labeled by Padagis Israel Pharmaceuticals Ltd. The product's dosage form is and is administered via form.This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package.

Is NDC 45802-238 included in the NDC Directory?

No, Alogliptin And Pioglitazone with product code 45802-238 is excluded from the NDC Directory because it was discontinued by the manufacturer. The product was first marketed by Padagis Israel Pharmaceuticals Ltd on April 08, 2016 and its listing in the NDC Directory is set to expire on September 13, 2024 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 45802-238-65?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 30.

What is the 11-digit format for NDC 45802-238-65?

The 11-digit format is 45802023865. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-245802-238-655-4-245802-0238-65